News
ACADIA’s $1B+ 2025 revenue outlook is driven by NUPLAZID and DAYBUE, with ACP-101 offering optional upside despite risks.
Juvenile-adolescent rats produce ultrasonic vocalizations characteristic of a pleasant sensation in response to repeated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback